Literature DB >> 20540029

Bone morphogenetic protein-7 expression is down-regulated in human clear cell renal carcinoma.

Nikolina Basic-Jukic1, Tvrtko Hudolin, Margareta Radic-Antolic, Marijana Coric, Renata Zadro, Zeljko Kastelan, Josip Pasini, Daniela Bandic-Pavlovic, Petar Kes.   

Abstract

BACKGROUND: Recent studies demonstrated that the expression pattern of bone morphogenetic protein-7 (BMP-7) is altered in different tumors. We determined expression of BMP-7 in human clear cell renal carcinoma (CCRC).
METHODS: Samples from cancer and corresponding healthy tissue were obtained from 20 patients who underwent nephrectomy for CCRC. Expression of BMP-7 mRNA was determined by reverse transcriptase polymerase chain reaction (RT-PCR), and protein expression was analyzed by immunohistochemistry.
RESULTS: RT-PCR showed strong down-regulation of BMP-7 mRNA in cancer tissue. Immunohistochemistry revealed expression of BMP-7 in normal renal tissue, with almost complete loss of BMP-7 expression in malignant cells of 6 patients (30%). After 3 years of follow-up, 5 out of 6 patients with high BMP-7 mRNA expression were alive and disease-free, compared with 9 out of 14 patients with low BMP-7 mRNA expression.
CONCLUSIONS: BMP-7 mRNA and protein expression were down-regulated in CCRC. Further prospective studies are needed to characterize the role of BMP-7 in human CCRC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20540029     DOI: 10.5301/jn.2010.2020

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  5 in total

1.  Expression of bone morphogenetic proteins 4, 6 and 7 is downregulated in kidney allografts with interstitial fibrosis and tubular atrophy.

Authors:  Vesna Furic-Cunko; Petar Kes; Marijana Coric; Tvrtko Hudolin; Zeljko Kastelan; Nikolina Basic-Jukic
Journal:  Int Urol Nephrol       Date:  2015-05-12       Impact factor: 2.370

2.  Expression of bone morphogenetic protein-2 and -7 in urinary bladder cancer predicts time to tumor recurrence.

Authors:  Bolesław Kuzaka; Marek Janiak; Krzysztof H Włodarski; Piotr Radziszewski; Paweł K Włodarski
Journal:  Arch Med Sci       Date:  2015-03-18       Impact factor: 3.318

3.  Clinical Significance of ADAMTS19, BMP7, SIM1, and SFRP1 Promoter Methylation in Renal Clear Cell Carcinoma.

Authors:  Raimonda Kubiliute; Algirdas Zalimas; Arnas Bakavicius; Albertas Ulys; Feliksas Jankevicius; Sonata Jarmalaite
Journal:  Onco Targets Ther       Date:  2021-10-05       Impact factor: 4.147

Review 4.  BMP signaling and its paradoxical effects in tumorigenesis and dissemination.

Authors:  Lijie Zhang; Yingnan Ye; Xinxin Long; Pei Xiao; Xiubao Ren; Jinpu Yu
Journal:  Oncotarget       Date:  2016-11-22

5.  Bone morphogenic proteins-2, -4, -6 and 7 in non-muscle invasive bladder cancer.

Authors:  Tvrtko Hudolin; Zeljko Kastelan; Ahmad El-Saleh; Mirko Bakula; Marijana Coric; Petar Kes; Davor Tomas; Nikolina Basic-Jukic
Journal:  Oncol Lett       Date:  2019-12-13       Impact factor: 2.967

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.